Login / Signup

Dasiglucagon for the treatment of congenital hyperinsulinism: a randomised phase 3 trial in infants and children.

Paul S ThorntonDiva D De LeonSusann EmptingDavid ZangenDavid M KendallSune BirchEva BøgeJelena IvkovicIndraneel Banerjee
Published in: The Journal of clinical endocrinology and metabolism (2023)
Clinically meaningful reductions in all CGM-recorded measures of hypoglycaemia support using dasiglucagon as a potential treatment for CHI.
Keyphrases
  • clinical trial
  • type diabetes
  • young adults
  • open label
  • combination therapy
  • replacement therapy
  • human health